Sorted By:

Relevance


Chart Pack: Value of Personalized Medicine

PhRMA  |  Report

Data and information found in this publication were drawn from a wide range of sources,  including government agency reports, peer?
https://www.phrma.org/report/chart-pack-value-of-personalized-medicine

Welcome to the new PhRMA.org

PhRMA  |  Blog Post

Explore an Interactive State Map to access comprehensive data on biopharmaceutical jobs and the industry’s overall economic impact, as well as local clinical trial activity across the United States.
http://catalyst.phrma.org/welcome-to-the-new-phrma.org

Industry Profile 2016

PhRMA  |  Report

The annual 2016 Pharmaceutical Industry Profile provides an overview of the sector, highlighting the latest medical advances, the impact of biopharmaceutical companies on the economy and the future of innovation....
https://www.phrma.org/report/industry-profile-2016

Why reauthorization of PDUFA matters

PhRMA  |  Blog Post

As the Senate now considers this important legislation, here are a few resources to help better explain why PDUFA is good for patients:  Find out how PDUFA benefits patients and advances medical innovation in this fact sheet.
http://catalyst.phrma.org/why-reauthorization-of-pdufa-matters

Clinical Trials: Neurological Disorders

PhRMA  |  Report

There are more than 2,000 clinical trials listed in the National Institutes of Health database – www.clinicaltrials.gov – for neurological disorders, such as Alzheimer’s disease, brain tumors, chronic pain, epilepsy, headache, multiple sclerosis and Par...
https://www.phrma.org/report/clinical-trials-neurological-disorders

Helping those affected by the 2017 hurricane season

PhRMA  |  Blog Post

Novartis Pharmaceuticals Corporation equipped associates with emergency preparedness resources prior to the hurricane’s arrival and is now working to provide additional support to displaced associates, including using travel resources as an additional means to help associates evacuate from the affected areas and offering the Fort Worth campus as a safe place to work, shower and eat.
http://catalyst.phrma.org/helping-those-affected-by-hurricane-harvey

Johnson & Johnson, Pfizer, Walgreens and other CEOs discuss value in the future of health care

PhRMA  |  Blog Post

Paz, executive vice president and chief medical officer, Aetna Driving Progress Moderator: Anna Edney, health regulation reporter, Bloomberg Panelists: Amy Abernethy, chief medical officer, chief scientific officer & senior vice president, oncology, Flatiron Health Mark McClellan, Robert J.
http://catalyst.phrma.org/janssen-pfizer-walgreens-and-other-ceos-discuss-value-in-the-future-of-health-care

New PwC report finds medicine spending still small share of health spending, concerns may trigger ‘false alarms’

PhRMA  |  Blog Post

” This is yet another report showing how the competitive biopharmaceutical market works to control costs and deliver new innovative treatments and cures patients desperately need.
http://catalyst.phrma.org/new-pwc-report-finds-medicine-spending-still-small-share-of-health-spending-concerns-may-trigger-false-alarms

New Report Shows Major Diseases Being Addressed With Over 230 Medicines in Development for Children

PhRMA  |  Press Release

The medicines listed in the report include treatments being developed by biopharmaceutical research companies in Illinois – Abbott Laboratories in Abbott Park, Hospira in Lake Forest, Neopharm in Waukegan and Takeda Pharmaceuticals, Astellas Pharma and Lundbeck, all located in Deerfield.
https://www.phrma.org/press-release/new-report-shows-major-diseases-being-addressed-with-over-230-medicines-in-development-for-children

Commercially-Insured Patients Pay Undiscounted List Prices for One In Five Brand Prescriptions, Accounting for Half of Out-of-Pocket Spending on Brand Medicines

PhRMA  |  Report

Patients with deductibles and coinsurance for prescription medicines pay cost-sharing that is based on the undiscounted list price of a medicine, rather than the discounted price negotiated by their health plan or pharmacy benefit manager (PBM). In the commercial market, one in five prescriptions...
https://www.phrma.org/report/commercially-insured-patients-pay-undiscounted-list-prices-for-one-in-five-brand-prescriptions-accounting-for-half-of-out-of-pocket-spending-brand-medicines

Disease modifying therapies for the management of multiple sclerosis save money and improve patient outcomes

PhRMA  |  Blog Post

Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources.
http://catalyst.phrma.org/disease-modifying-therapies-for-the-management-of-multiple-sclerosis-save-money-and-improve-patient-outcomes

UK Cancer Patients Face Increasing Coverage Restrictions Due to Centralized Cost-Effectiveness Standard, New Report Shows

PhRMA  |  Press Release

Washington, D.C. (July 10, 2014)  – New research results announced today quantify the extent to which centralized value assessments by the UK’s National Institute for Health and Care Excellence ...
https://www.phrma.org/press-release/uk-cancer-patients-face-increasing-coverage-restrictions-due-to-centralized-cost-effectiveness-standard-new-report-shows

Driving innovation through collaboration

PhRMA  |  Blog Post

here to read the entire report.
http://catalyst.phrma.org/driving-innovation-through-collaboration

Guest Post: The importance of a modern FDA in drug discovery

PhRMA  |  Blog Post

The ITIF report I mentioned notes that, in 1987, it took almost two and a half years on average for the FDA to review a new drug.
http://catalyst.phrma.org/the-importance-of-a-modern-fda-in-drug-discovery

New Report: Many Exchange Plans Burden the Most Vulnerable Patients with High Out-of-Pocket Costs for Vital Medicines; Patients left with limited access

PhRMA  |  Press Release

  The full report is available here.
https://www.phrma.org/press-release/new-report-many-exchange-plans-burden-the-most-vulnerable-patients-with-high-out-of-pocket-costs-for-vital-medicines-patients-left-with-limited-access

HIV Aids In this Together

PhRMA  |  Report

HIV/AIDS was once a death sentence. Today, it can be a manageable chronic disease. By working together, we can continue the progress toward a cure. This week, at the 2014 Research and Hope Awards, we are coming together to recognize those who have helped lead the fight against HIV/AIDS....
https://www.phrma.org/report/hiv-aids-in-this-together

The Value of Innovation in Oncology

PhRMA  |  Report

A new white paper by Boston Healthcare Associates examines how innovative medicines are driving significant progress in the fight against cancer. Though initial approval by the U.S. Food and Drug Administration is a tremendous milestone, ongoing research and accumulation of knowledge reveals bene...
https://www.phrma.org/report/the-value-of-innovation-in-oncology

New Drug Approvals in 2011

PhRMA  |  Report

America’s biopharmaceutical research companies obtained approval for 35 new medicines in 2011 from the U.S. Food and Drug Administration (FDA). The medicines include 24 new drugs (also called new molecular entities or NMEs), six therapeutic biologics, and five other biologics. Eleven of the new m...
https://www.phrma.org/report/new-drug-approvals-in-2011

Illegal trade barriers discriminate against U.S. innovators

PhRMA  |  Blog Post

Both Turkey and Russia give price advantages to local biopharmaceutical products purchased by the government – allowing local products to secure government contracts even if they are more expensive than imports.
http://catalyst.phrma.org/illegal-trade-barriers-discriminate-against-us-innovators

Executive Assistant – Law Department

PhRMA  |  PhRMA Career

Professional Exerpience / Requirements High School Diploma required; some college education or bachelor’s degree preferred A minimum of 3+ years assisting a senior level executive preferably in a legal environment and in an environment requiring the handling of confidential information and documents Excellent communications skills, both verbal and written, including good editing skills Strong interpersonal skills, diplomacy and ability to work as a member of a team Excellent organizational skills with the ability to handle multiple tasks simultaneously Ability to work well under pressure Strong computer skills should include Microsoft Office (Word, Excel, PowerPoint, etc.) web, and database management Previous experience working with financial administrative tasks, such as financial reports and processing invoices Ability to work independently as well as lead and assist other support staff, while exercising good judgment  Ability to do some basic research; preferably have a basic understanding of legal research, processes and court filings  Who we are The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.
https://www.phrma.org

Ask About Adherence: Q&A on appointment-based medication synchronization

PhRMA  |  Blog Post

Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources.
http://catalyst.phrma.org/ask-about-adherence-qa-on-appointment-based-medication-synchronization

Harnessing the power of real-world evidence to benefit patients through PDUFA VI

PhRMA  |  Blog Post

To help unleash the promise of RWE, the Prescription Drug User Fee Act (PDUFA) VI reauthorization will provide additional resources to the U.S.
http://catalyst.phrma.org/harnessing-the-power-of-real-world-evidence-to-benefit-patients-through-pdufa-vi

Chart Pack: Biopharmaceuticals in Government Programs

PhRMA  |  Report

This chart pack features key facts about prescription medicines in four major government programs—Medicare, Medicaid, the US Department of Veterans Affairs (VA), and the 340B program. Medicare insures many of the nation’s retirees and disabled persons and covers medicines primarily through Part D...
https://www.phrma.org/report/chart-pack-biopharmaceuticals-in-government-programs

Biopharmaceuticals in Perspective: Chart Pack 2013

PhRMA  |  Report

This chart pack provides facts and figures about prescription medicines and their role in the health care system. Topics include medicines’ impact on health and quality of life, the drug discovery and development process, biopharmaceutical spending and costs, the challenge of treatment gaps and i...
https://www.phrma.org/report/biopharmaceuticals-in-perspective-chart-pack-2013

Researching Cancer Medicines: Setbacks and Stepping Stones

PhRMA  |  Report

A cancer diagnosis can be devastating to individuals faced with the disease, along with their families and caregivers supporting them in their fight. While recent scientific advances have led to improved prevention, earlier diagnoses, and innovative treatments for many cancers, there is still tre...
https://www.phrma.org/report/researching-cancer-medicines-setbacks-and-stepping-stones

You have reviewed the first 225 results out of 1009. Each page contains 25 results. You're on page 9.

prev 7 8 9 10 11 12 next